These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 22582047

  • 1. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
    Barber TW, Duong CP, Leong T, Bressel M, Drummond EG, Hicks RJ.
    J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer.
    You JJ, Wong RK, Darling G, Gulenchyn K, Urbain JL, Evans WK.
    J Thorac Oncol; 2013 Dec; 8(12):1563-9. PubMed ID: 24389439
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
    Gregory DL, Hicks RJ, Hogg A, Binns DS, Shum PL, Milner A, Link E, Ball DL, Mac Manus MP.
    J Nucl Med; 2012 Jul; 53(7):1007-15. PubMed ID: 22677701
    [Abstract] [Full Text] [Related]

  • 6. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.
    Duong CP, Demitriou H, Weih L, Thompson A, Williams D, Thomas RJ, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):759-69. PubMed ID: 16470369
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
    Siva S, Byrne K, Seel M, Bressel M, Jacobs D, Callahan J, Laing J, Macmanus MP, Hicks RJ.
    J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.
    Cochet A, Dygai-Cochet I, Riedinger JM, Humbert O, Berriolo-Riedinger A, Toubeau M, Guiu S, Coutant C, Coudert B, Fumoleau P, Brunotte F.
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):428-37. PubMed ID: 24196916
    [Abstract] [Full Text] [Related]

  • 11. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Malik V, Johnston C, O'Toole D, Lucey J, O'Farrell N, Claxton Z, Reynolds JV.
    Dis Esophagus; 2017 Feb 01; 30(3):1-8. PubMed ID: 27862622
    [Abstract] [Full Text] [Related]

  • 12. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
    Duong CP, Hicks RJ, Weih L, Drummond E, Leong T, Michael M, Thomas RJ.
    Eur J Nucl Med Mol Imaging; 2006 Jul 01; 33(7):770-8. PubMed ID: 16550384
    [Abstract] [Full Text] [Related]

  • 16. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
    Torrance AD, Almond LM, Fry J, Wadley MS, Lyburn ID.
    Surgeon; 2015 Feb 01; 13(1):19-33. PubMed ID: 24206935
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 01; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 19. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Davey K, Heriot AG, Mackay J, Drummond E, Hogg A, Ngan S, Milner AD, Hicks RJ.
    Dis Colon Rectum; 2008 Jul 01; 51(7):997-1003. PubMed ID: 18461399
    [Abstract] [Full Text] [Related]

  • 20. The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification.
    Cochet A, David S, Moodie K, Drummond E, Dutu G, MacManus M, Chua B, Hicks RJ.
    Cancer Imaging; 2014 Apr 22; 14(1):13. PubMed ID: 25608599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.